Market Research Logo

Greece Pharmaceuticals and Healthcare Report Q1 2016

Greece Pharmaceuticals and Healthcare Report Q1 2016

BMI View: A poor record of implementing new legislation and the enduring public scepticism of genericmedicines indicate that the country's push to increase the prescription of generic medicines to 40% will failto produce the desired generic medicine uptake in the face of austerity. The government's focus onincreasing the consumption of generic medicines alongside persistent debt problems within the healthsystem highlights Greece as a challenging market for innovative drugmakers.

Headline Expenditure Projections

Pharmaceuticals: EUR4.96bn (USD6.64bn) in 2014 to EUR4.95bn (USD5.44bn) in 2015 -0.2% in localcurrency terms and -18.1% in US dollar terms. Forecast revised upwards from Q415 due to improvedmacroeconomic outlook.

Healthcare: EUR16.17bn (USD21.67bn) in 2014 to EUR15.38bn (USD16.92bn) in 2015 -4.9% in localcurrency terms and -21.9 in US dollar terms. Forecast unchanged from Q415.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Greece 2013-2019)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Greece 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Greece 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Greece 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Greece 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Greece 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Greece 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Greece 2011-2019)
OTC Drug Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Greece 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Greece 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Greece 2013-2019)
Industry Risk Reward Index
Central And Eastern Europe Risk/Reward Index - Q1 2016
Greece Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Regime
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Greece 2009-2014)
Table: Healthcare Personnel (Greece 2009-2014)
Table: Healthcare Activity (Greece 2009-2014)
Healthcare Insurance
Research and Development
Clinical Trials
Epidemiology
Competitive Landscape
Table: Multinational Market Activity
Pharmaceutical Retail Sector
Company Profile
Alapis Pharma
Elpen
Genesis Pharma
Kleva
Lavipharm
Pharmathen
Vianex
Demographic Data
Demographic Forecast
Table: Population Headline Indicators (Greece 1990-2025)
Table: Key Population Ratios (Greece 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Greece 1990-2025)
Table: Population By Age Group (Greece 1990-2025)
Table: Population By Age Group % (Greece 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report